Esmolol Articles
FDA clears APP's generic Esmolol
16 May 2005
Resovist recommended for approval in Japan
22 July 2002
1992 SEES SMALLER COMPANY MERGERS
10 January 1994
BOC PURCHASE
8 February 1993
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
